- Home
- ZYME vs OFG Comparison
ZYME vs OFG Comparison
Compare ZYME & OFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZYME | OFG |
|---|---|---|
| Founded | 2003 | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZYME | OFG |
|---|---|---|
| Price | $26.43 | $40.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 4 |
| Target Price | $32.75 | ★ $45.75 |
| AVG Volume (30 Days) | ★ 589.6K | 253.1K |
| Earning Date | 11-06-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 2.93% |
| EPS Growth | N/A | ★ 6.55 |
| EPS | N/A | ★ 4.40 |
| Revenue | $134,481,000.00 | ★ $624,004,000.00 |
| Revenue This Year | $63.57 | N/A |
| Revenue Next Year | $89.45 | $1.02 |
| P/E Ratio | ★ N/A | $9.31 |
| Revenue Growth | ★ 116.21 | N/A |
| 52 Week Low | $9.03 | $33.15 |
| 52 Week High | $28.49 | $46.11 |
Technical Indicators
Market Signals| Indicator | ZYME | OFG |
|---|---|---|
| Relative Strength Index (RSI) | 57.49 | 44.82 |
| Support Level | $26.10 | $41.75 |
| Resistance Level | $26.91 | $42.44 |
| Average True Range (ATR) | 0.95 | 0.70 |
| MACD | -0.25 | -0.18 |
| Stochastic Oscillator | 49.84 | 26.14 |
Price Performance
Historical ComparisonAbout ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About OFG OFG Bancorp
OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.